• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-1MEF filed by Blue Water Acquisition Corp.

    6/9/25 9:57:29 PM ET
    $BLUW
    Get the next $BLUW alert in real time by email
    S-1MEF 1 forms-1mef.htm S-1MEF

     

    As filed with the U.S. Securities and Exchange Commission on June 9, 2025.

     

    Registration No. 333-

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM S-1
    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933

     

     

    Blue Water Acquisition Corp. III
    (Exact name of registrant as specified in its charter)

     

     

    Cayman Islands   6770   33-2301550
    (State or other jurisdiction of
    incorporation or organization)
      (Primary Standard Industrial
    Classification Code Number)
      (I.R.S. Employer
    Identification Number)

     

    15 E. Putnam Avenue

    Suite 363

    Greenwich, CT 06830

    (203) 489-2110
    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

     

     

    Joseph Hernandez

    15 E. Putnam Avenue

    Suite 363

    Greenwich, CT 06830

    (203) 489-2110
    (Name, address, including zip code, and telephone number, including area code, of agent for service)

     

     

    Copies to:

     

    Mitchell S. Nussbaum, Esq.
    Andrei Sirabionian, Esq.
    Loeb & Loeb LLP
    345 Park Avenue
    New York, NY 10154
    (212) 407-4000
     

    Stephen P. Alicanti, Esq.
    DLA Piper LLP (US)
    1251 Avenue of the Americas

    New York, NY 10020

    (212) 335-4500

     

     

    Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement.

     

    If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. ☐

     

    If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☒ 333-285075

     

    If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

     

    If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ☐ Accelerated filer ☐
    Non-accelerated filer ☒ Smaller reporting company ☒
        Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

    This Registration Statement shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule 462(b) under the Securities Act of 1933, as amended.

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    This Registration Statement on Form S-1 (this “Registration Statement”) is being filed by Blue Water Acquisition Corp. III, a blank check company incorporated as a Cayman Islands exempted company (the “Registrant”), pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and General Instruction V to Form S-1. This Registration Statement relates to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-285075), initially filed by the Registrant on February 20, 2025 and declared effective by the Securities and Exchange Commission (the “Commission”) on June 9, 2025 (the “Prior Registration Statement”).

     

    This Registration Statement covers the registration of an additional 2,300,000 of the Registrant’s units, each consisting of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The required opinions of counsel and related consents and accountant’s consent are attached hereto and filed herewith. Pursuant to Rule 462(b), the contents of the Prior Registration Statement, including the exhibits thereto, are incorporated by reference into this Registration Statement.

     

    CERTIFICATION

     

    The Registrant hereby certifies to the Commission that (1) it has instructed its bank to pay the filing fee set forth in Exhibit 107 filed herewith by a wire transfer of such amount to the Commission’s account at U.S. Bank as soon as practicable (but no later than the close of business as of June 10, 2025), (2) it will not revoke such instructions, (3) it has sufficient funds in the relevant account to cover the amount of such filing fee and (4) it will confirm receipt of such instructions by its bank during regular business hours no later than June 10, 2025.

     

     

     

     

    Part II

     

    Information not required in prospectus

     

     

    Item 16. Exhibits and Financial Statement Schedules.

     

    (a) Exhibits. All exhibits filed with or incorporated by reference in the Registration Statement on Form S-1 (File No. 333-285075) are incorporated by reference into, and shall be deemed a part of, this Registration Statement, and the following additional exhibits are filed herewith, as part of this Registration Statement:

     

    Exhibit Index

     

    Exhibit No.   Description
    5.1   Opinion of Loeb & Loeb LLP.
    5.2   Opinion of Forbes Hare, Cayman Islands counsel to the Registrant.
    23.1   Consent of Elliott Davis, PLLC.
    23.2   Consent of Loeb & Loeb LLP (included on Exhibit 5.1).
    23.3   Consent of Forbes Hare (included on Exhibit 5.2).
    107   Filing Fee Table.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Greenwich, Connecticut, on the 9th day of June, 2025.

     

      Blue Water Acquisition Corp. III
       
      By: /s/ Joseph Hernandez
      Name: Joseph Hernandez
      Title: Chief Executive Officer

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.

     

    Name   Position   Date
             
    /s/ Joseph Hernandez   Chief Executive Officer and Director   June 9, 2025
    Joseph Hernandez   (principal executive officer)    
             
    /s/ Martha F. Ross   Chief Financial Officer   June 9, 2025
    Martha F. Ross   (principal financial and accounting officer)    
             
        Director    
    Timothy N. Coulson        
             
    /s/ Trevor L. Hawkins   Director   June 9, 2025
    Trevor L. Hawkins        
             
        Director    
    Ish S. Dugal        
             
    /s/ Laurent D. Hermouet   Director   June 9, 2025
    Laurent D. Hermouet        

     

     

     

    Get the next $BLUW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BLUW

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BLUW
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Clarus Therapeutics Closes Transaction With Blue Water, Debuts as a Publicly Traded Company to Develop Androgen and Metabolic Therapies

      Business combination with Blue Water Acquisition Corp., a special purpose acquisition company, completed on September 9, 2021 Combined company to be renamed Clarus Therapeutics Holdings, Inc. Clarus Therapeutics Holdings, Inc.'s common stock and warrants will commence trading on the Nasdaq Global Market on September 10, 2021, under the ticker symbols "CRXT" and "CRXTW," respectively Gross proceeds totaled approximately $25.3 million NORTHBROOK, Ill. and GREENWICH, Conn., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a specialty pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women (

      9/9/21 12:46:01 PM ET
      $BLUW
    • Blue Water Acquisition Corp. Announces Stockholder Approval of Business Combination with Clarus Therapeutics, Inc.

      GREENWICH, Conn., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ:BLUW), a special purpose acquisition company ("Blue Water"), today announced that its stockholders have voted to approve the proposed business combination (the "Business Combination") with Clarus Therapeutics, Inc., a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women ("Clarus") at its special meeting of stockholders (the "Special Meeting") held today, August 27, 2021. Holders of approximately 73.95% of Blue Water's issued and outstanding shares cast votes at the Special Meeting. Approximately 69.57% o

      8/27/21 12:58:37 PM ET
      $BLUW
      $BLUWU
      Business Services
      Finance
    • Blue Water Acquisition Corp. Announces Change of Special Meeting of Shareholders Date to August 27, 2021

      NEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ: BLUW) ("Blue Water" or the "Company"), a special purpose acquisition company (SPAC) that previously announced a planned business combination with Clarus Therapeutics, Inc. ("Clarus"), announced today that the special meeting of its stockholders (the "Special Meeting") originally scheduled for Thursday, August 12, 2021, is being postponed to Friday, August 27, 2021. As a result of this change, the Special Meeting will now be held at 10:00 a.m., Eastern Time, on August 27, 2021, exclusively via a live audio webcast at https://www.cstproxy.com/bluewateracquisition/2021. Also as a result of this c

      8/11/21 5:28:45 PM ET
      $BLUW
      $BLUWU
      Business Services
      Finance

    $BLUW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Blue Water Acquisition Corp.

      SC 13G - Blue Water Acquisition Corp. (0001817944) (Subject)

      5/10/21 4:05:31 PM ET
      $BLUW
    • SEC Form SC 13G/A filed

      SC 13G/A - Blue Water Acquisition Corp. (0001817944) (Subject)

      2/12/21 11:14:16 AM ET
      $BLUW
    • SEC Form SC 13G filed

      SC 13G - Blue Water Acquisition Corp. (0001817944) (Subject)

      2/12/21 6:34:28 AM ET
      $BLUW

    $BLUW
    SEC Filings

    See more
    • Blue Water Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

      8-K - Blue Water Acquisition Corp. III (0002050501) (Filer)

      6/12/25 6:04:42 AM ET
      $BLUW
    • SEC Form 424B4 filed by Blue Water Acquisition Corp.

      424B4 - Blue Water Acquisition Corp. III (0002050501) (Filer)

      6/10/25 7:55:15 PM ET
      $BLUW
    • SEC Form CERT filed by Blue Water Acquisition Corp.

      CERT - Blue Water Acquisition Corp. III (0002050501) (Filer)

      6/10/25 8:55:24 AM ET
      $BLUW

    $BLUW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Hernandez Joseph claimed ownership of 6,325,000 units of Class B ordinary shares (SEC Form 3)

      3 - Blue Water Acquisition Corp. III (0002050501) (Issuer)

      6/9/25 9:29:57 PM ET
      $BLUW
    • SEC Form 3 filed by new insider Hermouet Laurent Didier

      3 - Blue Water Acquisition Corp. III (0002050501) (Issuer)

      6/9/25 9:30:00 PM ET
      $BLUW
    • SEC Form 3 filed by new insider Dugal Ishdeep

      3 - Blue Water Acquisition Corp. III (0002050501) (Issuer)

      6/9/25 9:29:53 PM ET
      $BLUW

    $BLUW
    Financials

    Live finance-specific insights

    See more
    • Blue Water Acquisition Corp. Announces Date for Special Meeting of Stockholders to Vote on Transaction With Clarus Therapeutics, Inc.

      GREENWICH, Conn., July 30, 2021 /PRNewswire/ --  Blue Water Acquisition Corp. (NASDAQ:BLUW) ("Blue Water"), a special purpose acquisition company ("SPAC") led by Joseph Hernandez, today announced that it has scheduled a special meeting of its stockholders (the "Special Meeting") to, among other things, consider and vote on a proposal to approve the transactions contemplated by the previously announced merger agreement pursuant to which Clarus Therapeutics, Inc. ("Clarus") will merge with a wholly-owned subsidiary of Blue Water (the "Business Combination") and seek to become a publicly listed company. Subject to stockholder approval and satisfaction of customary closing conditions, Clarus and

      7/30/21 9:29:00 AM ET
      $BLUW